As a world-renowned leader in the field of Parkinson’s disease and movement disorders, Alessandro Di Rocco, MD has been the principal and co-investigator of numerous research studies including NIH and major national and international foundation-sponsored studies, having been awarded nearly two dozen grants to support his research efforts. Dr. Di Rocco sits on the Parkinson’s Foundation Board of Directors and the Melvin Yahr International Parkinson’s Disease Foundation, where he served as President for over eight years. Dr. Di Rocco also serves on many advisory boards and committees including the World Federation of Neurology Congress on Parkinson’s Disease. He has authored over 90 articles, 12 books and book chapters, over 125 abstracts and other publications.
Education
MD – Universita’ di Genova, Facolta’ di Medicina e Chirurgia, Genova, Italy
Residency
Neurology – Mount Sinai Medical Center
Fellowship
Movement Disorders and Geriatric Neurology – Mount Sinai Medical Center
Board
Certification Neurology – American Board of Psychiatry/Neurology
Clinical Trial & Research Interest
Integrated Model Care for Parkinson’s Disease and Other Neurological Disorders, Innovative Care Models for Advanced Parkinson’s Disease, Neurorestoration and Neuromodulation in Parkinson’s Disease and Related Disorders, Neurochemistry and Neuropharmacology of Parkinson’s Disease, Pharmacological Treatment of Parkinson’s Disease, Trans-Methylation in the Nervous System, Health Disparities in the Care of Neurological Patients
Awards & Professional
Recognition Travel Grant Award, International Federation of Parkinson’s Disease Foundations, 1994; Neurology Residency Teacher Award, Mount Sinai Medical Center, 1996; Medical Student’s Teacher Award, Mount Sinai Medical Center, 1996; Presidential Award, Spotlight Award-Recognition of Excellence, Mount Sinai Medical Center, 1997; The Nell and Herbert Singer Research Grant Award, 1998; Elected to the World Federation of Neurology, Committee on Extrapyramidal Research, 2002; European Academy Fellow and Achievement Award, 2003; America’s Top Physicians, Consumer’s Research Council of America, 2005–2013; Compassionate Doctor Award, American Medical Registry, 2013; Italian Heritage and Cultural Commission Award, 2015; Dean’s Honor Day, New York University, 2017
Professional Membership
Board of Directors, Parkinson’s Foundation, Miami-New York; Board of Directors, Melvin Yahr International Parkinson’s Disease Foundation; Board of Directors and Past President, Movement Disorders Society; American Academy of Neurology; International Association of Parkinsonism and Related Disorders; Parkinson Study Group
Specialty
Movement Disorders, Neurology Clinical Focus Parkinson’s Disease, Huntington’s Disease, Progressive Supranuclear Palsy, Multiple System Atrophy, Corticobasal Degeneration, Abnormal Gait, Ataxia, Spasmodic Dysphonia, Tourette Syndrome, Botox, Restless Leg Syndrome, Hemifacial Spasm, Deep Brain Stimulation, Meige Syndrome, Normal Pressure Hydrocephalus, Spasmodic Torticollis, Blepharospasm, Dystonia, Involuntary Muscle Jerking, Spasticity, REM Behavior Disorder, Lewy Body Dementia, Essential Tremor, Movement Disorders
Hospital Affiliation
North Shore University Hospital, Lenox Hill Hospital, Long Island Jewish Medical Center
Patient Office
Northwell Health Physician Partners Neuroscience Institute at Great Neck, 611 Northern Boulevard, Suite 150, Great Neck, NY 11021, (516) 325-7000, Fax (516) 325-7001
Northwell Health Physician Partners Neurology at Lenox Hill, 130 East 77th Street, 8 Black Hall, New York, NY 10075, (516) 325-7000, Fax (516) 325-7001
Director, Movement Disorders Program, Northwell Health
Joining Northwell Health in 2017, Ruben I. Kuzniecky, MD is internationally recognized in the fields of epilepsy, epilepsy surgery and neuroimaging. Dr. Kuzniecky has been awarded numerous research grants including one from the National Institutes of Health to organize the Epilepsy Phenome/ Genome Project. Dr. Kuzniecky is widely published, having authored two books, over 300 peer-reviewed publications and 40 book chapters. He was one of the first scientists to identify and prove that mesial temporal sclerosis is identifiable by MRI. Dr. Kuzniecky has three patents for his work related to epilepsy and has several additional patent applications pending.
Internationally recognized for his clinical, research and teaching expertise, Souhel Najjar, MD has dedicated his career to the diagnosis and treatment of epilepsy of all ages, complex neurological disorders and autoimmune disorders of the central nervous system. Prior to his appointment at Northwell Health, Dr. Najjar was Senior Epilepsy Faculty as well as Director of Epilepsy Quality Assurance and Founder and Director of the Neuroinflammation Research Group at NYU’s Comprehensive Epilepsy Center. Additionally, he was Director of Neurosciences and Stroke at Staten Island University Hospital. Dr. Najjar’s work has been widely published, and he is a reviewer for several peer-reviewed journals.
Education
MD – Damascus University Faculty of Medicine
Residency
Anatomic/Clinical Pathology – Albany Medical Center Hospital; Neurology – Albany Medical Center Hospital
Fellowship
EEG/Epilepsy – New York University; Neuropathology – New York University
Board Certification
Neurology – American Board of Psychiatry/Neurology
Clinical Trial & Research Interest
Neuroinflammation and Epilepsy, Neuroinflammation and Psychiatric Illnesses, Autoimmune Encephalitis
Awards & Professional Recognition
Top Doctors in America, U.S. News and World Report, 2007; New York’s Best Doctors, New York Magazine, 2010–2014; Mystery Diagnosis, TLC, 2005; Featured, New York Post, 2009; Featured, Today Show, 2010; Featured, Katie Couric Show, 2012; Featured in the New York Times Best-Selling Novel, Brain on Fire, 2013; Co-Director, Scientific Planning Committee, Autoimmune Encephalitis Alliance, 2013–Present
Publications
Pearlman, D.M., Najjar, S.: Response to Steiner and Bogerts on N-Methyl-dAspartate Receptor Autoantibodies in Schizophrenia and Affective Disorders. Schizophrenia Research, March 2015; Najjar, S., et al.: Blood Levels of S-100 Calcium-Binding Protein B, High-Sensitivity C-Reactive Protein and Interleukin-6 for Changes in Depressive Symptom Severity after Coronary Artery Bypass Grafting: Prospective Cohort Nested Within a Randomized, Controlled Trial. PLOS One, October 20, 2014; Pearlman, D.M., Najjar, S.: Meta-Analysis of the Association Between N-Methyl-Aspartate Receptor Antibodies and Schizophrenia, Schizoaffective Disorder, Bipolar Disorder and Major Depressive Disorder. Schizophrenia Research, August 2014; Najjar, S., et al.: Neurovascular Unit Dysfunction with Blood-Brain Barrier Hyperpermeability Contributes to Major Depressive Disorder: A Review of Clinical and Experimental Evidence. Journal of Neuroinflammation, December 1, 2013; Najjar, S., et al.: Neuroinflammation and Psychiatric Illness. Journal of Neuroinflammation, April 1, 2013; Najjar, S., et al.: Glia and Epilepsy: Excitability and Inflammation. Trends in Neurosciences, March 2013; Najjar, S., et al.: Extralimbic Autoimmune Encephalitis Associated with Glutamic Acid Decarboxylase Antibodies: An Underdiagnosed Entity? Epilepsy & Behavior, 2011; Najjar, S., et al.: Immunology and Epilepsy. Reviews in Neurological Diseases, December 12, 2007
Specialty
Neurology, EEG/Epilepsy
Clinical Focus
Epilepsy
Clinical Neurophysiology
Autoimmune Disorders of the Central Nervous System
Hospital Affiliation
Lenox Hill Hospital, Staten Island University Hospital
Patient Office
Northwell Health Physician Partners Neurology at Lenox Hill, 130 East 77th Street, 8 Black Hall, New York, NY 10075, (212) 434-6400, Fax (212) 434-2279
Northwell Health Physician Partners Neurology at Staten Island, 1110 South Avenue, Suite 300, Staten Island, NY 10314, (718) 226-5700, Fax (718) 226-9654
As a Board-Certified Pediatric Neurologist, Theodora Andriotis, DO furthered her training by specializing in Epilepsy and interpreting Electroencephalograms (EEGs). She has devoted her career to care for children with epilepsy and other neurological disorders. Dr. Andriotis has personal experience in Autism Spectrum Disorder and Developmental Disabilities, which are often seen as comorbid conditions with Childhood Epilepsy. Her expertise, dedication and tremendous empathy provides parents peace of mind when trusting their child’s health in her care.
Assistant Professor, Department of Neurology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
A board-certified neurologist with fellowship training in cerebrovascular neurology, Catherine Arnold, MD is highly committed to providing expert and compassionate patient-centered care. Dr. Arnold earned her medical degree at the University of North Dakota School of Medicine and Health Sciences. From there, she completed her neurology residency and fellowship in vascular neurology at Mayo Clinic in Rochester, Minnesota. Before joining Northwell Health, Dr. Arnold served as a stroke specialist and neuro-hospitalist.
Education
MD – University of North Dakota School of Medicine and Health Sciences
Residency
Neurology – Mayo Clinic, Rochester, MN
Fellowship
Vascular Neurology – Mayo Clinic, Rochester, MN
Board Certification
Neurology – American Board of Psychiatry/Neurology
Research Interests
Cerebrovascular neurology with special interest in acute stroke care; Embolic stroke of undetermined source (ESUS); Secondary stroke prevention; Hospital practice quality improvement
Professional Recognition
A. B. Baker Teacher Recognition Award, American Academy of Neurology, 2021; Teacher of the Year, Mayo Clinic, 2020; Henry Woltman Award for Clinical Excellence, Mayo Clinic, 2019
Professional Membership
American Academy of Neurology
American Heart/Stroke Association
Publications
Arnold C, Vemuri P, Rabinstein AA, Mielke MM, Przybelski SA, Kantarci K, Jones DT, Brown RD Jr, Knopman DS, Petersen RC, Jack CR Jr, Graff-Radford J. Frequency of Acute and Subacute Infarcts in a Population-Based Study. Mayo Clin Proc. 2018 March., Rinaldo L, Arnold CE, Chen JJ, Lanzino G. Clinical Reasoning: Headaches and double vision in a 68-year-old woman. Neurology. 2018 August., Arnold C, Lanzino G, Chen JJ, Brinjikji W, Eckel LJ, Boes CJ. Carotid Cavernous Fistula Mimicking Hemicrania Continua: A Case Report. Headache. 2019 Sept., Yost M, Arnold CA, Rabinstein AA, Klaas J, Aakre JA, Brown RD Jr, Mielke MM, Knopman DS, Lowe V, Petersen RC, Jack CR Jr, Vemuri P, Graff-Radford J. Incidence of Convexal Subarachnoid Hemorrhage in the Elderly: The Mayo Clinic Study of Aging. J Stroke Cerebrovasc Dis. 2019 Dec., Larson AS, Rinaldo L, Arnold CE, Young NP, Lanzino G. Spontaneous Vertebral Arteriovenous Fistula Mimicking Brachial Radiculoplexopathy. World Neurosurg. 2020 June.
Specialty
Neurology
Clinical Focus
Cerebrovascular Disease
Hospital Neurologist
Hospital Affiliation
Lenox Hill Hospital
Derek Chong, MD, MSc is a fellowship-trained neurologist committed to providing superior, compassionate neurological care with a focus in EEG and epilepsy. He has won numerous awards including the Epilepsy Foundation of America’s Post-Doctoral Research Training Fellowship for Clinicians and twice has won the Early Career Physician-Scientist award from the American Epilepsy Society & the Milken Family Foundation to fund his research endeavors. This research has focused on identifying the mechanism of drug resistance in epilepsy, the markers of respiration and gas exchange during seizures and the role of autoimmunity in epilepsy and brain function.
Education
MD – University of Calgary; MSc – McMaster University
Residency
Neurology – University of Western Ontario
Fellowship
Neurophysiology – Columbia University Medical Center; EEG/Epilepsy – Columbia University
Board Certification
Clinical Neurophysiology – American Board of Psychiatry/ Neurology; Sleep Medicine – American Board of Psychiatry/Neurology; Neurology – American Board of Psychiatry/Neurology
Professional Membership
American Academy of Sleep Medicine; Canadian Society of Clinical Neurophysiology; Corresponding Member, American Epilepsy Society; Member, American Academy of Neurology
Publications
Chong, D.J., Duggan, P. and EPGP Investigators: Ictal Fear & Epilepsy Phenome/ Genome Project: Associations with Age, Gender and other Experiential Phenomena. Epilepsy & Behavior, July 29, 2016; Chong, D.J., Lerman, A.M.: Anti-Convulsants in Current Practice. Current Neurology and Neuroscience Reports; Dugan, P., Carlson, C., Bluvstein, J., Chong, D., Friedman, D., Kirsch, H.: Auras in Generalized Epilepsy. Neurology; Chong, D.: 15-Year-Old Patient with Encephalopathy and Seizures After Vaccination. Epilepsy Currents, January 2014; Farwell, M.D., Chong, D.J., Yasuhiko, I., Bae, J., Easwaramoorthy, B., Ichise, M.: Imaging P-Glycoprotein Function in Rats Using [11C]-N-Desmethyl-Loperamide. Annals of Nuclear Medicine, April 10, 2013; Chong, D.J.: The Medical Management of Epilepsy. Panminerva Medica, December 2011; Mirsattari, S.M., Gofton, T.E., Chong, D.J.: Misdiagnosis of Epileptic Seizures as Manifestations of Psychiatric Illnesses. Canadian Journal of Neurological Sciences, May 2011; Chong, D.J., Bazil, C.W.: Update on Antiepileptic Drugs. Current Neurology and Neuroscience Reports, 2010; Chong, D.J., Strong, M.J., Skrum, M., Kalapos, P.Z., Hammond, R.: Clinico-Pathological-Correlation: Sub-Acute Weakness, Deafness and Respiratory Failure in a 58-Year-Old Woman. Canadian Journal of Neurological Sciences, 2005; Yung, B., Moeller, J.J., Bitar, M., Chong, D.J.: Hemispheric-Onset Creutzfeldt-Jakob Disease with Concordant MRI and EEG Findings. Neurology, October 19, 2010
Specialty
Clinical Neurophysiology, Sleep Medicine, Neurology
Clinical Focus
Epilepsy
Sleep Disorder
Brain Inflammation
Electroencephalography
Electromyography
Evoked Potentials
Polysomnograms
Sleep Medicine
Clinical and Surgical Approaches to Epilepsy
Hospital Affiliation
Lenox Hill Hospital
Patient Office
Northwell Health Physician Partners Neurology at Lenox Hill, 130 East 77th Street, New York, NY 10075, (212) 434-6400, Fax (212) 434-2279
Northwell Health Physician Partners Neurology at Chelsea South, 22 West 15th Street, New York, NY 10011, (212) 434-6400, Fax (212) 434-2279
Robert A. Duarte, MD joined the North Shore-LIJ Health System in 1991 and is Director of the Pain Center and Assistant Professor of Neurology at Hofstra North Shore-LIJ School of Medicine. Dr. Duarte is board certified in neurology, pain medicine and headache medicine and is also a certified acupuncturist. His clinical interests also include traumatic brain injury and concussion.
Dr. Duarte attended Ponce School of Medicine and completed his residency in neurology at Nassau University Medical Center. Post residency Dr. Duarte completed a fellowship in pain/headache management at Long Island Jewish Medical Center.
Dr. Duarte is President Elect of the New York State Pain Society and a member of the American Headache Society and American Academy of Neurology. He also sits on the Admissions Committee for Hofstra North Shore-LIJ School of Medicine and is board member of the College of Health Professions in Syosset, NY.
Dr. Duarte has written multiple chapters on pain, headache, complementary medicine and traumatic brain injury. He lectures extensively and continues to participate in multiple research projects on pain and headache.
Joining Northwell Health in 2015, Luca Giliberto, MD, PhD is an attending neurologist at North Shore University Hospital and Long Island Jewish Medical Center and a researcher at the Alzheimer’s Center at Feinstein Institute for Medical Research. Dr. Giliberto’s research interests include new approaches to the treatment of Alzheimer’s disease, the pathogenesis of Alzheimer’s disease, focusing on amyloid/tau signaling and brain susceptibility to aging and the mechanisms of traumatic brain encephalopathy. He is actively involved in outreach and educational projects on Alzheimer’s disease and related dementias in the Long Island community.
Education
MD – Universita Degli Studi di Milano, Milano, Italy; PhD – Universita Degli Studi di Genova, Genova, Italy
Residency
Internal Medicine – Nassau University Medical Center; Neurology – North Shore University Hospital
Board Certification
Neurology – American Board of Psychiatry/Neurology
Clinical Trial & Research Interest
Alzheimer’s Disease Treatments, Genetic Correlates of Alzheimer’s Disease, New Models of Alzheimer’s Disease, Pathogenic Mechanisms of Alzheimer’s Disease, Pathogenic Mechanisms of Traumatic Brain Encephalopathy
Awards & Professional Recognition
Important Scientific Contribution as Young Investigator, Annual Meeting, Italian Neurological Society, 2007
Professional Membership
American Academy of Neurology; Society for Neurosciences
Publications
Biundo, F., d’Abramo, C., Tambini, M.D., Zhang, H., Del Prete, D., Vitale, F., Giliberto, L., Arancio, O., D’Adamio, L.: Abolishing Tau cleavage by Caspases at Aspartate 421 Causes Memory/Synaptic Plasticity Deficits and Pre-Pathological Tau Alterations. Translational Psychiatry, 2017
Guglielmotto, M., Monteleone, D., Boido, M., Piras, A., Giliberto, L., Borghi, R., Vercelli, A., Fornaro, M., Tabaton, M., Tamagno, E.: Aβ1-42-Mediated Down-Regulation of Uch-L1 is Dependent on NF-κB Activation and Impaired BACE1 Lysosomal Degradation. Aging Cell, October 2012
Tamayev, R., Matsuda, S., Giliberto, L., Arancio, O., D’Adamio, L.: APP Heterozygosity Averts Memory Deficit in Knockin Mice Expressing the Danish Dementia BRI2 Mutant. EMBO Journal, May 17, 2011
Specialty
Neurology
Clinical Focus
Alzheimer’s Disease and Degenerative Dementias
Cognitive Disorders
Vascular Dementia
Traumatic Brain Encephalopathy
Hospital Affiliation
North Shore University Hospital, Long Island Jewish Medical Center, Lenox Hill Hospital, Long Island Jewish Forest Hills
Patient Office
Northwell Health Physician Partners Neuroscience Institute at Great Neck, 611 Northern Boulevard, Suite 150, Great Neck, NY 11021, (516) 325-7000, Fax (516) 325-7001
Dr. Libman earned a bachelor of science degree and a medical degree from the McGill University school of medicine, Montréal, Canada. He completed a residency in neurology at the Albert Einstein College of medicine and a fellowship in stroke at Columbia Presbyterian Medical Center/New York Neurological Institute.
Dr. Libman is a vice chairman of neurology. He joined the health system in 1993 as a stroke neurologist at LIJ. Under Dr. Libman’s leadership, LIJ became one of the leading centers in the country for clinical trials testing innovative treatments for stroke, including participating in the landmark National Institutes of Health study on the clot busting drug TPA, which revolutionized the treatment of acute stroke. Under Dr. Libman’s leadership, LIJ won the American Heart Associations’ highest awards for quality of care of stroke patients. In his leadership role of the North Shore-LIJ Stroke Task Force, Dr. Libman oversaw the accreditation of all health system hospitals as New York State Department of Health designated primary stroke centers.
Dr. Libman has published extensively in various neurological and stroke journals, with numerous book chapters and has presented his work at national and international meetings. He is a professor of neurology at the Hofstra Northwell school of medicine, a member of the American Academy of Neurology, American Heart/American Stroke Association and the American Medical Association. He has been given the teacher of the year award on several occasions.
Neurology, North Shore University Hospital
Assistant Professor, The Feinstein Institutes for Medical Research Associate Professor, Neurology, Zucker School of Medicine
Martin Heinrich Niethammer
Curriculum Vitae
Degrees and Qualifications
M.D. Harvard University – MIT, Cambridge, MA, USA 1997 – 2002
Ph.D., Neuroscience Harvard University 1993 – 1998
Diplom in Biology# Eberhard-Karls-Universität, Tübingen, Germany 1988 – 1993
(Dipl. Rer. Nat)
#Diplom = 5-year tertiary degree equivalent to B.Sc. and M.Sc. degrees)
Licensure and Certifications
Board certified in Neurology by the American Board of Psychiatry and Neurology, May 8, 2007
Full medical license in the state of New York
Academic Positions
01/2020 – present Associate Professor of Neurology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
05/2019 – present Assistant Professor, Feinstein Center for Neuroscience, The Feinstein Institutes for Medical Research, Manhasset, NY, USA
07/2009 – 12/2019 Assistant Professor of Neurology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
07/2008 – present Attending Neurologist, North Shore University Hospital and Harvey Cushing Institute
of Neuroscience, Great Neck, NY, USA
07/2010 – 2016 Adjunct Assistant Professor of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
07/2008 – 2010 Assistant Professor of Neurology, Albert Einstein College of Medicine, Bronx, NY,
USA
Education and Training
07/2006 – 06/2008 The Neurological Institute, Center for Parkinson’s Disease New York, NY, USA
Fellowship in Movement disorders
07/2003 – -06/2006 New York Presbyterian Hospital, The Neurological Institute, New York, NY, USA
Residency in Neurology
07/2002 – 06/2003 Beth Israel Deaconess Medical Center, Boston, MA, USA
Internal Medicine Internship
09/1997 – 06/2002 Harvard Medical School/MIT, Boston/Cambridge, MA, USA
Medical Student, Health Sciences & Technology program
11/1998 – 07/2000 Harvard Medical School, Boston, MA, USA
Postdoctoral research in neuroscience§
09/1993 – 11/1998 Harvard University Graduate School of Arts and Sciences, Cambridge, MA
Predoctoral student in neuroscience
Spring/Sum 1993 Department of Neuroscience, Brown University, Providence, RI, USA
Research in neuroscience, Diplom thesis*
08/1991 – 06/1992 Brown University , Providence, RI
Exchange student*
09/1988 – 09/1993 Eberhard-Karls-Universität, Tübingen, Germany
Diplom in biology (Animal Physiology, Mathematics, Genetics)
Spring 1988 Warner-Lambert/Parke-Davis, Ann Arbor, MI
Internship in Molecular Biology
§ Laboratory of Dr. Li-Huei Tsai, Department of Pathology, Harvard Medical School, Boston, MA 02215, USA
* Laboratory of Dr. John P. Donoghue, Department of Neuroscience, Brown University, Providence, RI 02912, USA
Honors/Awards
NIH Poster Presentation Award 10/2012: “Expression of a cognitive metabolic network in Parkinson’s disease correlates with dopaminergic function in the caudate nucleus”
Fellowship, Albert J. Ryan Foundation, 1996-1998
Athena E. Martinos Fellowship, 1998/1999
Research Support
Ongoing
R01 NS105979 David Eidelberg (PI) 09/16/19–5/31/24
Neurovascular Effects of Dopamine Replacement Therapy in Parkinson’s Disease.
The goal of this study is to investigate different features of neurovascular dysregulation
(levodopa-mediated dissociation), hypercapnic vasoreactivity, blood-brain-barrier (BBB)
permeability, and microglial activation in individual PD subjects as they develop levodopa-induced
dyskinesia (LID).
Role: Co-investigator
Grant #16325 03/01/19-06/20/22
The Michael J Fox Foundation for Parkinson’s Research
Genotypic Influences on Network Progression in Parkinson’s Disease. This PET and fMRI imaging study will provide complementary information concerning mechanisms of disease progression in Parkinson’s disease (PD) patients with and without GBA mutations.
Role: Co-Investigator
1R21NS111301-01 Ramdhani (PI) 2020-present
Computational modeling of 60Hz STN DBS for gait disorder in Parkinson’s disease
Role: Co-Investigator
N/A Niethammer (PI) 03/01/2017 – present
Collaborative Center for X-linked Dystonia Parkinsonism
Identification of a Network-based Imaging Biomarker in X-linked Dystonia-Parkinsonism (XDP)
The goal of this project is to examine the structure/function abnormalities underlying XDP and whether these changes constitute useful biomarkers of the disorder. As this disease is endemic to the Philippines, as part of the project we will be setting up PET imaging infrastructure at St. Luke’s Medical Center, Quezon City, Philippines
Role: PI
Completed
P50 NS071675-01 David Eidelberg (PI) 09/30/10–08/31/15
NIH/NINDS
“Morris K. Udall Center of Excellence for Parkinson’s Disease”
The goal of the Udall Center program is to utilize a multidisciplinary research approach to elucidate the fundamental causes of PD as well as to improve the diagnosis and treatment of patients with Parkinson’s and related neurodegenerative disorders.
Role: Co-Investigator
RO1 NS072514-02 David Eidelberg (PI) 04/01/2011-03/31/2015
NIH/NINDS
“Network-based Imaging Biomarkers in Sporadic Dystonia“
The goal of this project is to examine the structure/function abnormalities underlying the sporadic forms of torsion dystonia and whether these changes constitute useful biomarkers of the disorder.
N/A Niethammer and Eidelberg (Co-PIs) 01/01/09 – 12/31/10
Bachmann-Strauss Dystonia and Parkinson Foundation
Network-Based Imaging Biomarkers in Sporadic Dystonia
The goal of this project is to examine the structure/function abnormalities underlying the sporadic forms of torsion dystonia and whether these changes constitute useful biomarkers of the disorder.
Role: Co-PI
N/A David Eidelberg (PI) 07/01/10 – 06/30/12
Empire Clinical Research Investigator Award, New York State
The Molecular Basis for Cognitive Impairment in Parkinson’s Disease: A Multi-tracer PET Study
This program encourages teaching hospitals and Graduate Medical Education (GME) consortia to train physicians as clinical researchers to advance biomedical research in New York’s academic health centers.
Role: Trainee
Clinical Trials
2020 – present “A Phase 3, Randomized Double-Blind, Placebo-Controlled, Parallel Arm, Multicenter Study Evaluating the Efficacy and Safety of Pridopidine in Patients with Early Stage of Huntington Disease”
Role: Medical Monitor PI: Ralf Reilmann, MD, and Andrew Feigin, MD
2020 – present A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated with Huntington’s Disease
Role: Medical Monitor PI: Ralf Reilmann, MD, and Andrew Feigin, MD
2015 – present “A phase 2, multicenter, randomized, double-blind, placebo controlled study in subjects with late prodromal and early manifest Huntington’s disease to assess safety, tolerability, pharmacokinetics, and efficacy of VX15/2503”
Role: Medical Monitor PI: Andrew Feigin, MD
2012 – 2015 “Disease Modifying Potential of Transdermal Nicotine in Early Parkinson’s Disease”.
Role: Independent rater. Site director: Andrew Feigin. MD
2010 – 2015 “Open-Label Continuation Treatment Study With Levodopa – Carbidopa Intestinal Gel in Subjects With Advanced Parkinson’s Disease and Severe Motor-Fluctuations Who Have Exhibited A Persistent and Positive Effect to Treatment In Previous Studies”.
Role: Sub-principal Investigator. Site director: Andrew Feigin, MD
Peer-reviewed publications
Ramdhani, R.A., Watts, J., Kline, M, Fitzpatrick ,T., Niethammer, M., and Khojandi ,A. (2023) Differential spatiotemporal gait effects with frequency and dopaminergic modulation in STN-DBS. Frontiers in Aging Neuroscience 15: doi: 10.3389/fnagi.2023.1206533
Niethammer, M., Tang, C.C., Jamora, R.D.G., Vo,A., Nguyen, N., Ma, Y., Peng, S., Waugh, J.L., Westenberger, A., and Eidelberg, D. (2023) A Network Imaging Biomarker of X-Linked Dystonia-Parkinsonism. Annals of Neurology 94(4): 684-695
Vo, A. , Nguyen. N., Fujita. K., Schindlbeck, K.A., Rommal, A., Bressman, S.B., Niethammer, M., and Eidelberg, D. (2023) Disordered network structure and function in dystonia: pathological connectivity vs. adaptive responses. Cerebral Cortex 33(11): 6943-6958
Dhawan, V., Niethammer, M., Lesser, M.L., Pappas, K.N., Hellman, M., Fitzpatrick, T.M., Bjelke. D., Singh, J., Quatarolo, L.M., Choi, Y.Y., Oh, A., Eidelberg, D., and Chaly, T. (2022) Prospective F-18 FDOPA PET imaging study in human PD. Nuclear Medicine and Molecular Imaging 56(3): 147-157
Vo, A., Schindlbeck. K.A., Nguyen, N., Rommal, A., Spetsieris, P.G., Tang, C.C., Choi, Y.Y., Niethammer, M., Dhawan, V, and Eidelberg, D. (2022) Adaptive and pathological connectivity responses in Parkinson’s disease brain networks. Cerebral Cortex 32(6): 1-16
Schindlbeck, K.A., Vo, A., Nguyen, N., Tang, C.C., Niethammer, M., Dhawan, V., Brandt, V., Saunders-Pullman, R., Bressman, S.B. and Eidelberg, D. (2020) LRRK2 and GBA Variants Exert Distinct Influences on Parkinson’s Disease-Specific Metabolic Networks. Cerebral Cortex 30(5): 2867-2878
Niethammer, M., Tang, C.C., Vo, A., Nguyen, N., Spetsieris, P., Dhawan, V., Ma, Y., Small, M., Feigin, A., During, M.J., Kaplitt, M.G., and Eidelberg, D. (2018) Gene therapy reduces Parkinson’s disease symptoms by reorganizing functional brain connectivity. Science Translational Medicine 10(469): eaau0713
Jourdain, V.A., Schindlbeck, K.A., Tang, C.C., Niethammer, M., Choi, Y.Y., Markowitz, D., Nazem, A., Nardi, D., Carras, N., Feigin, A., Ma, Y., Peng, S., Dhawan, V., and Eidelberg, D. (2017) Increased putamen hypercapnic vasoreactivity in levodopa-induced dyskinesia. JCI Insight 2(20): e96411.
Niethammer, M., Tang, C.C., LeWitt, P.A., Rezai, A.R., Leehey, M.A.. Ojemann, S.G., Flaherty, A.W., Eskandar, E.N., Kostyk, S.K., Sarkar, A., Siddiqui, M.S., Tatter, S.B., Schwalb, J.M., Poston, K.L., Henderson, J.M., Kurlan, R.M., Richard, I.H., Sapan, C.V., Eidelberg, D., During, M.J., Kaplitt, M.G., and Feigin, A. (2017) Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson’s disease. JCI Insight 2(7): e90133.
Strafella, A.P., Bohnen, N.I., Perlmutter, J.S., Eidelberg, D., Pavese , N., Van Eimeren, T., Piccini, P., Politis, M., Thobois, S., Ceravolo, R., Higuchi, M., Kaasinen, V., Masellis, M., Peralta, M.C., Obeso, I., Pineda-Pardo, J.Á., Cilia, R., Ballanger, B., Niethammer, M., and Stoessl, J.A. (2017) Molecular imaging to track Parkinson’s disease and atypical parkinsonisms: New imaging frontiers. Movement Disorders 32 (2):181-192.
Shakkottai, V.G., Batla, A., Bhatia, K., Dauer, W.T., Dresel, C., Niethammer, M., Eidelberg, D., Raike, R.S., Smith, Y., Jinnah, H.A., Hess, E.J., Meunier, S., Hallett, M., Fremont, R., Khodakhah, K., LeDoux, M.S., Popa, T., Gallea, C., Lehericy, S., Bostan, A.C. and Strick, P.L. (2017) Current Opinions and Areas of Consensus on the Role of the Cerebellum in Dystonia. Cerebellum 16(2):577-594.
Mattis, P.J., Niethammer, M., Sako, W., Tang, C.C., Nazem, A., Gordon, M.L., Brandt, V., Dhawan, V. and Eidelberg D (2016) Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases. Neurology 87 (18):1925-1933.
Davis, M.Y., Johnson, C.O., Leverenz, J.B., Weintraub, D., Trojanowski, J.Q., Chen-Plotkin, A., Van Deerlin, V.M., Quinn, J.F., Chung, K.A., Peterson-Hiller, A.L., Rosenthal, L.S., Dawson, T.M., Albert, M.S., Goldman, J.G., Stebbins, G.T., Bernard, B., Wszolek, Z.K., Ross, O.A., Dickson, D.W., Eidelberg, D., Mattis, P.J., Niethammer, M., Yearout, D., Hu, S.C., Cholerton, B.A., Smith, M., Mata, I.F., Montine, T.J., Edwards, K.L. and Zabetian, C.P. (2016) Association of GBA mutations and the E326K polymorphism with motor and cognitive progression in Parkinson disease. JAMA Neurology 73 (10): 1217-1224.
Sako, W., Fujita, K., Vo, A., Rucker, J.C., Rizzo, J.R., Niethammer , M., Carbon, M., Bressman, S.B., Uluğ, A.M., and Eidelberg, D. (2015) The visual perception of natural motion: abnormal task-related neural activity in DYT1 dystonia. Brain 138 (Pt 12): 3598-609.
Vo, A., Sako, W., Niethammer, M., Carbon, M., Bressman, S.B., Uluğ, A.M. and Eidelberg, D. (2015) Thalamocortical connectivity correlates with chenotypic variability in dystonia. Cerebral Cortex 25: 3086-3094.
Niethammer, M., Tang, C.C., Feigin, A., Allen, P.J., Heinen, L., Hellwig, S., Amtage, F., Hanspal, E., Vonsattel, J.P., Poston, K.L., Meyer, P.T., Leenders, K.L. and Eidelberg, D. (2014) A disease-specific metabolic brain network associated with corticobasal degeneration. Brain 137 (Pt 11): 3036-3046.
Lerner, R.P., Niethammer, M., and Eidelberg, D. (2013) Understanding the anatomy of dystonia: determinants of penetrance and phenotype. Current Neurology and Neuroscience Reports 13 (11): 401-408.
Niethammer, M., Tang, C.C., Ma, Y., Mattis, P.J., Ko, J.H., Dhawan, V. and Eidelberg, D (2013) Parkinson’s disease cognitive network correlates with caudate dopamine. NeuroImage 78: 204-209.
Niethammer, M. and Eidelberg, D. (2012) Metabolic brain networks in translational neurology: concepts and applications. Annals of Neurology 72 (5): 635-647.
Niethammer, M., Feigin, A., and Eidelberg, D. (2012) Functional Neuroimaging in Parkinson’s Disease. Cold Spring Harbor Perspectives in Medicine 2 (5): a009274.
Niethammer, M., Carbon-Correll, M. Argyelan, M., and Eidelberg, D. (2011) Hereditary Dystonia as a Neurodevelopmental Circuit Disorder: Evidence from Neuroimaging. Neurobiology of disease 42: 202-209.
Argyelan M., Carbon, M., Niethammer, M., Ulug, A.M., Voss, H.U., Bressman, S.B., Dhawan, V., and Eidelberg, D. (2009) Cerebellothalamocortical connectivity regulates penetrance in dystonia. Journal of Neuroscience 29: 9740-9747.
Carbon, M., Niethammer, M., Peng, S., Raymond, D., Dhawan, V., Chaly, T., Ma, Y., Bressman, S., and Eidelberg, D. (2009) Abnormal striatal and thalamic dopamine neurotransmission: genotype-related features of dystonia. Neuroloy 72: 2097-2103.
Niethammer, M. and Ford, B. (2007) Permanent lithium-induced cerebellar toxicity: Three cases and review of literature. Movement Disorders 22 (4): 570-573.
Winawer, M.R., Kuperman, R., Niethammer, M., Sherman, S., Rabinowitz, D., Guell, I P., Ponder, C.A., and Palmer, A.A. (2007) Use of chromosome substitution strains to identify seizure susceptibility loci in mice. Mammalian Genome 18: 23-31.
Long, J.F., Tochio, H., Wang, P., Fan, J.S., Sala, C., Niethammer, M., and Sheng. M. (2003) Supramodular structure and synergistic target binding of the N-terminal tandem PDZ domains of PSD-95. Journal of Molecular Biology 327 (1): 203-214.
Niethammer, M., Smith, D.S., Ayala, R., Peng, J., Ko, J., Lee, M.-S., Morabito, M., and Tsai, L.-H. (2000) NUDEL is a novel cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron 28: 697-711.
Smith, D.S., Niethammer, M., Ayala, R., Zhou, Y., Gambello, M.J., Wynshaw-Boris, A., and Tsai, L.-T. (2000) Regulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1. Nature Cell Biology 2: 767-775.
Passafaro, M., Sala, C., Niethammer, M., and Sheng, M. (1999) Microtubule binding by CRIPT and its potential role in synaptic clustering of PSD-95. Nature Neuroscience 2: 1063-1069.
Niethammer, M., Valtschanoff, J.G., Kapoor, T.M., Allison, D.W., Weinberg, R.J., Craig, A.M., and Sheng, M. (1998) CRIPT, a novel postsynpatic protein that binds to the third PDZ domain of PSD-95/SAP90. Neuron 20: 693-707.
Niethammer, M., Kim, E., and Sheng, M. (1996) Interaction between the C-terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases. The Journal of Neuroscience 16: 2157-2163.
Kim, E., Niethammer, M., Rothschild, A., Jan, Y.N., and Sheng, M. (1995) Clustering of Shaker-type K+ channels by multiple members of the PSD-95 family of membrane-associated guanylate kinases. Nature 378:85-88.
Niethammer, M. and Plenge, M. (1992) Reaction of homing pigeons to olfactorial stimuli and its relation to their intensity. Journal of Ornithology 133: 287-290.
Book chapters and other publications
Unadkat, P., Niethammer, M., and Eidelberg, D. (2023) Metabolic Networks in Parkinson’s Disease. In: Mechanisms and Emerging Therapies in Tremor Disorders, Grimaldi, G., Manto. M., eds. Springer, Chapter 20: 427-446.
Niethammer, M. (2021) Corticobasal Degeneration. In: Hybrid PET/MR Neuroimaging, Franceschi, A.M., Franceschi, D., eds. Springer, Chapter 32: 373-386.
Niethammer, M. and Franceschi, A.M. (2021) Parkinson’s Disease. In: Hybrid PET/MR Neuroimaging, Franceschi, A.M., Franceschi, D., eds. Springer, Chapter 36: 421-439..
Niethammer, M. and Eidelberg, D. (2019) Network Imaging in Parkinsonian and Other Movement Disorders: Network Dysfunction and Clinical Correlates. In: International Review of Neurobiology, Vol 144, Politis, M., ed., Elsevier. Chapter 5: 143-184.
Niethammer, M. and Eidelberg, D. (2017) Functional Imaging in Huntington Disease. In: Handbook of Clinical Neurology, Vol 144 – Huntington Disease, Feigin, A.S., Anderson, K.E., eds., Academic Press, San Diego. Chapter 21: 263-287
Tang, C.C., Niethammer, M., Allen, P.J., Leenders, K.L., and Eidelberg, D. (2014) PET and SPECT imaging in Parkinsonian Syndromes. In: PET and SPECT in Neurology, Dierckx, R.A.J.O., Otte, A., de Vries, E.F.J., van Waarde, A., eds., Springer, Heidelberg. Chapter 28: 619-638.
Niethammer, M. and Feigin, A. (2011) Imaging Applications to Parkinson’s Disease Clinical Trials. In: Imaging in Parkinson’s Disease, Eidelberg, D., ed., Oxford University Press, New York. Chapter 17: 181-190
Niethammer, M. and Eidelberg,.M. (submitted 2010) Neuroimaging Studies in the Evaluation of Patients with Movement Disorders. In: Tremor, Parkinson’s Disease & Related Movement Disorders. LeWitt, P., ed., Cambridge University Press, Cambridge, UK.
Dhawan, V, Niethammer, M, and Eidelberg, D (2009) Can functional imaging be used as a biomarker for PD? PDonline research (Michael J Fox Foundation)
Niethammer, M. and Sheng, M. (1998) Identification of ion channel-associated proteins using the yeast-two hybrid system. Methods in Enzymology 293: 104-122.
Selected presentations at scientific conferences
Niethammer, M., Tang, C.C., Jamora, R.D.G., Vo,A., Nguyen, N., Ma, Y., Peng, S., Waugh, J.L., Westenberger, A., and Eidelberg, D. (2023) A Network Imaging Biomarker of X-Linked Dystonia-Parkinsonism. 2023 International Congress of Parkinson’s Disease and Movement Disorders. Movement Disorders 38 (Suppl 1): S662
Dresel, C., Tang, C., Niethammer, M., Eidelberg, D. (2016) Derivation of a levodopa-related pattern (LDRP) from metabolic brain images in Parkinson’s disease. Presentation 1347 at OHBM 2016, Geneva, Switzerland.
Niethammer, M. Tang, C., Poston, K., Min, K.H., Feigin, A., Eidelberg, D. (2011) An Abnormal Metabolic Network in Corticobasal Degeneration. 63rd Annual Meeting of the American Academy of Neurology, Neurology, 2011; 76(Suppl 4): A640. (platform presentation 4/14/2011)
Tang, C., Niethammer, M., Gerber, N., Mattis, P., Ma, Y., Eidelberg, D. (2011) Expression of a Cognitive Metabolic Network in Parkinson’s Disease Correlates with Dopaminergic Function in the Caudate Nucleus. 63rd Annual Meeting of the American Academy of Neurology, Neurology, 2011; 76(Suppl 4): A489-90.
Niethammer, M, Carbon-Corell, M, Peng, S, Raymond, D, Dhawan, V, Ma, Y, Chaly, T, Bressman, S, Eidelberg, D (2009) Impaired dopaminergic neurotransmission in hereditary torsion dystonia. 61st Annual Meeting of the American Academy of Neurology, platform presentation S33.
Niethammer, M, Schumacher, H.C., Bateman, B.T., and Henchcliffe, C (2007) Outcome of acute ischemic stroke in hospitalized Parkinson’s disease patients. Eleventh International Congress of Parkinson’s Disease and Movement Disorders. Movement Disorders 22 (Suppl 16): 550.
Niethammer, M., Daras, M., and Frucht, S. (2007) Chorea and compulsive behavior – an unusual presentation of myasthenia gravis. Eleventh International Congress of Parkinson’s Disease and Movement Disorders. Movement Disorders 22 (Suppl 16): 96.
Niethammer, M, Schumacher, H.C., Bateman, B.T., Louis, E.C., and Henchcliffe, C. (2006) Patterns of acute hospitalization of Parkinson’s disease patients in the USA. Tenth International Congress of Parkinson’s Disease and Movement Disorders. Movement Disorders 21 (Suppl 15): P794.
Niethammer, M, and Sheng, M. (1997) Clustering of Shaker-type K+ channels by multiple members of the PSD-95 family of membrane-associated guanylate kinases. Oral presentation. Proceedings of the 25th Göttingen neurobiology conference. Stuttgart: Thieme, 1997
Selected lectures
200 Years of Parkinson’s Disease. Neurology Grand Rounds, North Shore University Hospital, Manhasset, NY, September 29, 2017
Motor Complications in Parkinson’s Disease. Centricity Series Biomedical Research Symposia, Manhasset, NY, February 25, 2016
Medical Treatment for Tic Disorders. Centricity Series Biomedical Research Symposia, Manhasset, NY, June 5, 2013
What is Parkinson’s Disease? Centricity Series Biomedical Research Symposia, Manhasset, NY, January 25, 2012
Managing Non-Motor Symptoms in Parkinson’s Disease. PharmEd CME conference, Flushing, NY, September 29, 2010
Neuroimaging and Dystonia. Spasmodic Torticollis Symposium, Elizabeth, NJ, September 25, 2010
Chemodenervation: Current Approaches and Techniques in Managing the Parkinson’s Disease Patient. CME Symposium on Movement Disorders, Teaneck, NJ, November 14, 2009
Parkinson’s disease – Imaging and treatment. Huntington Hospital medical grand rounds, Huntington, NY. September 10, 2009
Update on Parkinson’s disease – Etiology, Imaging, and treatment. Neuroscience grand rounds, Southside Hospital. June 3, 2009
Diagnosis. Management, and outlook for people living with Parkinson’s disease. PDF symposium at Long Island University. March 7, 2009
Parkinson’s disease. CERC North Shore lecture. December 18, 2008
Parkinson’s disease. Young Onset PD support group, Smithtown, NY. October 14, 2008
Movement Disorders and Parkinson’s disease. Community talk. August 15, 2008
Selected professional activities
June 19-23, 2016
20th International Congress or Parkinson’s Disease and Movement Disorders, Berlin, Germany
June 16-20, 2013
19th Annual Meeting of the Organization for Human Brain Mapping, Seattle, WA
June 17-21, 2012
16th International Congress or Parkinson’s Disease and Movement Disorders, Dublin, Ireland
June 5-9, 2011
15th International Congress or Parkinson’s Disease and Movement Disorders, Toronto, Canada
April 9-16, 2011
63rd Annual Meeting of the American Academy of Neurology, Honolulu, HI
April 25-May 2, 2009
61st Annual Meeting of the American Academy of Neurology, Seattle ,WA
June 3-10, 2007
11th International Congress or Parkinson’s Disease and Movement Disorders, Istanbul, Turkey
October 28- November 2, 2006
10th International Congress or Parkinson’s Disease and Movement Disorders, Kyoto, Japan
July 28-31, 2006
A comprehensive review of Movement Disorders for the Clinical Practitioner, Aspen, CO
April 1-8, 2006
58th Annual Meeting of the American Academy of Neurology, San Diego, CA
November 7-12,1998
26th Annual Meeting of the Society for Neuroscience, Los Angeles, CA
May 1997
25th Göttingen Neurobiology Conferences – From Membrane to Mind
October 25-30, 1997
25th Annual Meeting of the Society for Neuroscience, New Orleans, LA
November 13-18, 1994
22nd Annual Meeting of the Society for Neuroscience, Miami Beach, FL
Professional organizations and societies
2017 – present Member, Huntington Study Group
2008 – present Member, American Academy of Neurology
2006 – present Member, Movement Disorder Society
Having dedicated his career to the evaluation and treatment of patients with Parkinson’s and other movement disorders, Ritesh A. Ramdhani, MD is a leader in his field. Prior to joining Northwell Health, Dr. Ramdhani held leadership positons at several organizations and is actively involved in resident and student teaching, contributing to the development of tomorrow’s physicians. Dr. Ramdhani’s research interests include using motion sensor technology to better characterize Parkinson’s motor symptoms and subsequently develop computational frameworks to potentially predict medication and deep brain stimulation responses.
Education
MD – Mount Sinai Medical School
Residency
Neurology – Mount Sinai Medical Center
Fellowship
Movement Disorders – Mount Sinai Medical Center
Board Certification
Neurology – American Board of Psychiatry and Neurology
Clinical Trial & Research Interest
Investigation of the Use of Wearable Sensor Technology to Improve the Application of Existing Therapies for Parkinson’s Disease and Tremor, Site Principal Investigator for the APPRISE Trial, which Studies the Impact of the Parkinson’s Kinetograph (PKG) from Global Kinetics, Inc. on Decision Making Among Movement Disorders Specialists
Awards & Professional Recognition
Resident Member, Alpha Omega Alpha, 2012; House Staff Physician of the Year, Mount Sinai Medical Center, 2010; Employee Appreciation Award for Outstanding Patient Care, Mount Sinai Medical Center, 2008
Professional Membership
American Academy of Neurology; Movement Disorders Society; American Neurological Association; Editorial Board, International Journal of Neurology and Neurotherapy, 2014; Editorial Board, Journal of Clinical Movement Disorders, 2016; International Journal of Neuroscience, 2015; Reviewer, Journal of Neurological Sciences, 2016; Reviewer, Journal of Clinical Movement Disorders, 2016; Reviewer, Tremor and Other Hyperkinetic Movements, 2017; Reviewer, Journal of Parkinson’s Disease, 2017
Publications
Khojandi, A., Shylo, O., Mannini, L., Kopell, B.H., Ramdhani, R.A.: Stratifying Parkinson’s Patients with STN-DBS into High Frequency or 60Hz-Frequency Modulation using a Computational Model. Neuromodulation, May 8, 2017; doi: 10.1111/ner.12607 [PMID 28480524]
Ramdhani, R.A., Khojandi, A., Shylo, O., Kopell, B.H.: Optimizing Clinical Assessments in Parkinson’s Disease Through the Use of Wearable Sensors and Data Driven Modeling. Frontiers In Computational Neuroscience, 12:72. https://doi.org/10.3389/ fncom.2018.00072
Ramdhani, R.A., Kumar, V., Velickovic, M., Frucht, S.J., Tagliati, M., Simonyan, K.: What’s special about task in dystonia? A voxel-based morphometry and diffusion tensor imaging study. Mov Disord, August 2014;29(9):1141-50 [PMID 24925463]
Specialty
Neurology
Clinical Focus
Parkinson’s Disease
Atypical Parkinsonism
Tremor
Dystonia
Restless Leg Syndrome
Hemifacial Spasm
Tic Disorder
Chorea
Botulinum Toxin Therapy
Deep Brain Stimulation
Hospital Affiliation
North Shore University Hospital, Lenox Hill Hospital
Patient Office
Northwell Health Physician Partners Neuroscience Institute at Great Neck, 611 Northern Boulevard, Suite 150, Great Neck, NY 11021, (516) 325-7000, Fax (516) 325-7001
Northwell Health Physician Partners Neurology at Lenox Hill, 130 East 77 Street, 8 Black Hall, New York, NY 10075, (516) 325-7000, Fax (516) 325-7001
Board certifications
Neurology – American Board of Psychiatry / Neurology-Neurology
Psychiatry – American Board of Psychiatry / Neurology-Psychiatry
Pain Management – American Board of Psych / Neurology-Pain Medicine
Academic titles
Associate Professor, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Education
Georgetown University School of Medicine
Residencies
New York University School of Medicine
New York University School of Medicine
Fellowships
Thomas Jefferson University Hospital & Med College
Affiliations
Long Island Jewish Medical Center
North Shore University Hospital
Northwell Health Neuroscience Institute
Katz Institute for Women’s Health
Director, Parkinson’s, Movement and Motor Disorders Neurorehabilitation Unit, Glen Cove Hospital
Board certifications
Neurology – American Board of Psychiatry / Neurology
Academic titles
Assistant Professor, Neurology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Education
MD – Bashrirsky Medical Institute, Russia
Residencies
Neurology, North Shore University Hospital, Manhasset, NY
Fellowships
Neurorehabilitation, North Shore University Hospital, Manhasset, NY
Affiliations
Glen Cove Hospital
Long Island Jewish Medical Center North Shore University Hospital Northwell Health Neuroscience Institute
Specialty
Neurorehabilitation
Clinical focus
Parkinson’s and Movement disorders neurorehabilitation Motor disorders neurorehabilitation
Brain Injury neurorehabilitation
Daniel M Torres is a Clinical Assistant Professor of Neurology at Lenox Hill Hospital. His practice is in general neurology with focus on neuromuscular disorders and management of the sequelae of mild traumatic brain injury. He completed his medical and neurological training at NYU. His interest in brain injury started in residency when he became intimately involved with NYU concussion center education. He then spent 7 years as co-director of the NYU Concussion Center where he was the primary neurologist for clinical concussion evaluations, ran yearly continuing medical education courses on concussion and participated in quality improvement and research efforts for the center.
Kendra Cheng graduated from Johnson & Wales University PA program. She first worked in internal medicine before coming to Lenox Hill Hospital’s Stroke Neurology service in 2018. At Lenox Hill, she has collaborated to create the ACP neurology team here to cover 24/7 stroke codes and consults, which has now expanded to also cover the inpatient stroke unit. Lenox Hill has since achieved its first ever Comprehensive Stroke Center Certification.
NP in Family Health
Project Manager, Neurology Service Line
Dr. Erica Meltzer is a clinical neuropsychologist in the Department of Neurology at Northwell Health and Assistant Professor at the Zucker School of Medicine at Hofstra/Northwell. She specializes in neuropsychological assessment of patients with epilepsy and is the dedicated neuropsychologist for the Comprehensive Epilepsy Center at North Shore University Hospital. Dr. Meltzer earned her doctorate from The Graduate Center of the City University of New York and completed internship and fellowship training in the Department of Neurology at Northwell Health.
